SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-173863
Filing Date
2023-06-23
Accepted
2023-06-23 16:31:02
Documents
15
Period of Report
2023-06-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d499888d8k.htm   iXBRL 8-K 31997
2 EX-10.1 d499888dex101.htm EX-10.1 313181
3 EX-10.2 d499888dex102.htm EX-10.2 127254
4 EX-99.1 d499888dex991.htm EX-99.1 19855
  Complete submission text file 0001193125-23-173863.txt   735372

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA cprx-20230619.xsd EX-101.SCH 2872
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20230619_lab.xml EX-101.LAB 18758
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20230619_pre.xml EX-101.PRE 11725
9 EXTRACTED XBRL INSTANCE DOCUMENT d499888d8k_htm.xml XML 3526
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 231038183
SIC: 2834 Pharmaceutical Preparations